Home Mindray Subsidiary Wuhan Mindray Biomedical Technology Co., Ltd. Dissolved Amid Organizational Streamlining; Company Re-files Hong Kong IPO Prospectus

Mindray Subsidiary Wuhan Mindray Biomedical Technology Co., Ltd. Dissolved Amid Organizational Streamlining; Company Re-files Hong Kong IPO Prospectus

Dec 09, 2025 11:46 CST Updated 11:46
Mindray Scientific

Developer and Manufacturer of Medical Materials and Devices

Mindray

Medical Device R&D Manufacturer

图片

IVD Information compiled from AiqiCha

On December 3, inquiries on multiple credit platforms showed,Wuhan Mindray Bio-Medical Technology Co., Ltd. Cancellation.

Image
Image

The company was established on December 24, 2019, with a registered capital of 2 billion yuan,The business scope includes the production of Class I medical devices, sales of Class II medical devices, R&D of intelligent robots, etc., and isA wholly-owned subsidiary of Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Image

IVD Information speculates that Mindray's move might be to optimize the company's organizational structure and strengthen the company’s management over its subsidiaries.

At present, Mindray also has a main entity enterprise in Wuhan,Wuhan Mindray Scientific Co.,Ltd., the legal representative is also Han Le, established in 2005, with a registered capital of 2.3 billion yuan, and its business scope covers all aspects of medical devices.

Image

On August 5, 2025, Mindray's global second headquarters — the Mindray Wuhan Base, with a total investment of 4.5 billion yuan, officially opened.

图片

Mindray's Wuhan Base, located in Wuhan Guanggu Bio-city, covers an area of 110 mu and includes two major sub-projects: the Wuhan R&D Base and the production base. Mindray’s Wuhan Production Base is one of Mindray's seven global supply chain bases, leading the development of high-end manufacturing through digital construction. The base mainly produces medical products such as orthopedic materials, minimally invasive surgical instruments, and biological raw materials.
图片

图片

图片

Disclaimer: The articles marked with sources in this WeChat are reprints, intended solely for sharing purposes and do not represent the platform's position. If there are any copyright issues or other problems, please contact us as soon as possible, and we will make corrections immediately.